Expressiveness of global coagulation parameters in dilutional coagulopathy.
about
Early and individualized goal-directed therapy for trauma-induced coagulopathyA comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery.Predictive value of rotational thromboelastometry during cardiopulmonary bypass for thrombocytopenia and hypofibrinogenemia after weaning of cardiopulmonary bypass.Correction of hypothermic and dilutional coagulopathy with concentrates of fibrinogen and factor XIII: an in vitro study with ROTEMComparison of fibrin-based clot elasticity parameters measured by free oscillation rheometry (ReoRox ®) versus thromboelastometry (ROTEM ®).Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study.Preferential effects of low volume versus high volume replacement with crystalloid fluid in a hemorrhagic shock model in pigsEffect of haematocrit on fibrin-based clot firmness in the FIBTEM test.The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review.Management of traumatic haemorrhage--the European perspective.Perioperative course of FXIII in children undergoing major surgery.[Traumatic abruption of the placenta with disseminated intravascular coagulation].Comparison of the effects of a balanced crystalloid-based and a saline-based tetrastarch solution on canine whole blood coagulation and platelet function.Haemostatic profile of reconstituted blood in a proposed 1:1:1 ratio of packed red blood cells, platelet concentrate and four different plasma preparations.Effect of rapid fluid resuscitation using crystalloids or colloids on hemostasis in piglets.In vitro evaluation of canine hemostasis following dilution with hydroxyethyl starch (130/0.4) via thromboelastometry.Low dose of hydroxyethyl starch impairs clot formation as assessed by viscoelastic devices.
P2860
Q26853422-010857F2-9862-4E49-BB35-BCBBF1C795C4Q33396248-7B6629AC-A2EC-46C2-A1CD-EA4A5827F037Q33423408-DBD5F4AD-E88B-4BFB-83F6-FC580C1E464DQ34746641-00952DDB-BC0F-4C46-BE7D-A08268F42CA2Q35318068-C991D3A8-BCA0-446F-AB55-2ADDD02F4807Q36131612-DC5DFA73-EBE0-4B48-A15C-63CB682F03E9Q36131647-8065DA54-9670-4949-AD07-6D09117849CEQ37059236-16DF3DC3-B60A-4D41-BDCE-74B13F4D41F7Q37306739-678770DE-F265-4ED4-8BAF-27ABC652CF11Q37944502-6CBF3121-35A0-441F-AEB3-F2A6EBD0B9E0Q38273794-B704953D-1D3F-4C75-8236-2AC04B59E27FQ44868346-AB9F9DEC-85EF-4F61-8483-5E60BE9AE1B0Q46322459-720C5196-C563-4261-BDD8-B5EA1E863DC7Q47356474-A3FBA5AB-BA6D-471E-994B-DD6CC8068AFEQ47722397-A46C9D63-741A-477A-ACD5-84C3E1946C28Q48102404-BD424788-CD12-4212-8745-17501D076C8DQ50890786-386E8F2E-64B4-4B6D-9728-9544C17707DFQ52878553-C7ECACAE-D4B8-46F2-87EF-0DD65D0E2161
P2860
Expressiveness of global coagulation parameters in dilutional coagulopathy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Expressiveness of global coagulation parameters in dilutional coagulopathy.
@en
Expressiveness of global coagulation parameters in dilutional coagulopathy.
@nl
type
label
Expressiveness of global coagulation parameters in dilutional coagulopathy.
@en
Expressiveness of global coagulation parameters in dilutional coagulopathy.
@nl
prefLabel
Expressiveness of global coagulation parameters in dilutional coagulopathy.
@en
Expressiveness of global coagulation parameters in dilutional coagulopathy.
@nl
P2093
P356
P1476
Expressiveness of global coagulation parameters in dilutional coagulopathy.
@en
P2093
P304
P356
10.1093/BJA/AEQ199
P407
P577
2010-08-06T00:00:00Z